PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Pipexus
Presentation Product Chemical substance Chapter Items dispensed
Pipexus 0.26mg modified-release tablets
0409010W0BEAAAE
Pipexus Pramipexole Central Nervous System 1,776
Pipexus 0.52mg modified-release tablets
0409010W0BEABAF
Pipexus Pramipexole Central Nervous System 1,602
Pipexus 1.05mg modified-release tablets
0409010W0BEADAG
Pipexus Pramipexole Central Nervous System 1,287
Pipexus 1.57mg modified-release tablets
0409010W0BEAEAJ
Pipexus Pramipexole Central Nervous System 1,044
Pipexus 2.1mg modified-release tablets
0409010W0BEACAH
Pipexus Pramipexole Central Nervous System 930
Pipexus 3.15mg modified-release tablets
0409010W0BEAGAI
Pipexus Pramipexole Central Nervous System 608
Pipexus 2.62mg modified-release tablets
0409010W0BEAFAK
Pipexus Pramipexole Central Nervous System 580

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.